Wells GA - Search Results

1

How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

Boers M, Kirwan JR, Gossec L, Conaghan PG, D'Agostino MA, Bingham CO 3rd, Brooks PM, Landewé R, March L, Simon L, Singh JA, Strand V, Wells GA, Tugwell P. Boers M, et al. Among authors: wells ga. J Rheumatol. 2014 May;41(5):1025-30. doi: 10.3899/jrheum.131314. Epub 2014 Mar 1. J Rheumatol. 2014. PMID: 24584913

2

Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1992 Mar;19(3):436-43. J Rheumatol. 1992. PMID: 1578460

3

Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.

Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1992 Mar;19(3):444-50. J Rheumatol. 1992. PMID: 1578461

4

Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise.

Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1992 Mar;19(3):451-7. J Rheumatol. 1992. PMID: 1578462

5

Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Nov;18(11):1701-8. J Rheumatol. 1991. PMID: 1787492

6

Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.

Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Nov;18(11):1709-15. J Rheumatol. 1991. PMID: 1787493

7

Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.

Bellamy N, Buchanan WW, Esdaile JM, Fam AG, Kean WF, Thompson JM, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Nov;18(11):1716-22. J Rheumatol. 1991. PMID: 1787494

8

Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Dec;18(12):1893-900. J Rheumatol. 1991. PMID: 1795329

9

Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.

Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Dec;18(12):1908-15. J Rheumatol. 1991. PMID: 1795330

10

Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.

Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. Among authors: wells ga. J Rheumatol. 1991 Dec;18(12):1901-7. J Rheumatol. 1991. PMID: 1822109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

832 results

Search Page

Filters